Drug-eluting stent thrombosis after cilostazol withdrawal in a patient previously treated with triple antiplatelet therapy

Eui Im, Sang Hak Lee, Jung Sun Kim, Donghoon Choi, Yangsoo Jang

Research output: Contribution to journalArticle

1 Citation (Scopus)


Antiplatelet therapy has been shown to reduce cardiac events after coronary stenting. However, despite aggressive antiplatelet therapy, stent thrombosis remains a serious complication of coronary stenting with drug-eluting stent (DES). Although several predictors for DES thrombosis have been suggested by investigators, this serious condition is still not completely preventable now. In particular, patients undergoing non-cardiac surgery or invasive procedures with bleeding risk may interrupt antiplatelet therapy and occasionally experience stent thrombosis. We report a case of DES thrombosis after cilostazol withdrawal for colonoscopic polypectomy in a patient previously treated with triple antiplatelet therapy. The patient presented with acute myocardial infarction but survived after successful emergency coronary revascularization. We discuss a plausible mechanism for DES thrombosis in the described case.

Original languageEnglish
Pages (from-to)e55-e57
JournalInternational Journal of Cardiology
Issue number2
Publication statusPublished - 2009 Jun 26


All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this